Constance M. Chen, MD, MPH, FACS, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. Dr. Chen received her BA from Harvard College, MD from Stanford University School of Medicine, and MPH from Tulane School of Public Health and Tropical Medicine. She is currently Clinical Assistant Professor of Plastic Surgery at Weill Cornell Medical College and Clinical Assistant Professor of Plastic Surgery at Tulane University School of Medicine. www.constancechenmd.com
Breast reduction surgery is a relatively safe procedure. Though rare, risks are possible. Here are the 10 most common concerns after breast reduction surgery.
The Food and Drug Administration (FDA) issued a new warning for breast implants that requires healthcare providers to thoroughly communicate the risks and safety concerns associated with implants.
The stronger warning is appropriate for patients as many practitioners and patients were not aware of the earlier warnings or did not take them seriously. Risks linked to breast implants include infection, rupture, capsular contracture (when the body forms scar tissue around the implant), breast implant illness, and, in rare cases, breast implant-associated anaplastic large cell lymphoma. Anaplastic large cell lymphoma occurs in approximately 1 in 450 women with textured breast implants.